- Home
- SURG vs ICCM Comparison
SURG vs ICCM Comparison
Compare SURG & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ICCM
- Stock Information
- Founded
- SURG 2006
- ICCM 2006
- Country
- SURG United States
- ICCM Israel
- Employees
- SURG N/A
- ICCM N/A
- Industry
- SURG Advertising
- ICCM
- Sector
- SURG Consumer Discretionary
- ICCM
- Exchange
- SURG Nasdaq
- ICCM Nasdaq
- Market Cap
- SURG 58.6M
- ICCM 61.1M
- IPO Year
- SURG N/A
- ICCM N/A
- Fundamental
- Price
- SURG $2.71
- ICCM $0.83
- Analyst Decision
- SURG Strong Buy
- ICCM Strong Buy
- Analyst Count
- SURG 1
- ICCM 1
- Target Price
- SURG $9.50
- ICCM $2.50
- AVG Volume (30 Days)
- SURG 93.8K
- ICCM 2.4M
- Earning Date
- SURG 11-11-2025
- ICCM 11-25-2025
- Dividend Yield
- SURG N/A
- ICCM N/A
- EPS Growth
- SURG N/A
- ICCM N/A
- EPS
- SURG N/A
- ICCM N/A
- Revenue
- SURG $36,461,935.00
- ICCM $2,787,000.00
- Revenue This Year
- SURG $20.20
- ICCM $3.95
- Revenue Next Year
- SURG $121.54
- ICCM $266.15
- P/E Ratio
- SURG N/A
- ICCM N/A
- Revenue Growth
- SURG N/A
- ICCM N/A
- 52 Week Low
- SURG $1.05
- ICCM $0.51
- 52 Week High
- SURG $3.47
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- SURG 47.32
- ICCM 30.63
- Support Level
- SURG $2.51
- ICCM $0.93
- Resistance Level
- SURG $2.90
- ICCM $1.40
- Average True Range (ATR)
- SURG 0.15
- ICCM 0.08
- MACD
- SURG -0.02
- ICCM -0.02
- Stochastic Oscillator
- SURG 41.67
- ICCM 0.00
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.